Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults

Table 3

Classification/distribution of ADREs in the treatment groups and gender.

ADREs description	Overall	Treatment groups		Gender
		TLE	ZLE	Male	Female
Cutaneous	14 (31.1%)	11 (78.6%)	3 (21.4%)	4 (28.6%)	10 (71.4%)
GIT effects	10 (22.2%)	10 (100%)	0 (0%)	3 (21.4%)	7 (78.6%)
CNS effects	15 (33.3%)	14 (93.3%)	1 (6.7%)	5 (33.3%)	10 (66.7%)
Mitochondrial toxicity	6 (13.3%)	6 (100%)	0 (0%)	1 (16.7%)	5 (83.3%)
Total	45 (100%)
ADREs observed	3	3	0	0	3

The table shows the distribution of the specific ADREs experienced at each level of comparison under four broad classification.